Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

BMS-470539 reduces skin fibrosis and inflammation.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Two new compounds were found to effectively reduce hair growth in mice.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Tirzepatide may improve hair loss by reducing insulin resistance.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Hyaluronic acid successfully treated skin atrophy caused by corticosteroid injections.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

A young woman with skin issues and weight loss improved after treating her pancreatitis and using skin treatments.

Blocking mTORC1 reduces skin tumor growth in mice.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Noggin promotes skin tumors by activating certain cell signaling pathways.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.